Restoring UBE2N enzyme reduced liver fat and scarring in mice
Cedars-Sinai and collaborators found that the enzyme UBE2N falls in livers as metabolic steatotic disease progresses toward MASH. Restoring UBE2N in mouse livers cut fat buildup, inflammation and scarring, slowing markers of liver injury. About 100 million Americans have MASLD, and roughly 20 to 25 percent progress to MASH.
Where this came from. One outlet reported this. We read it, then wrote the sixty words above.